Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

2.07
+0.05002.48%
Post-market: 2.130.0600+2.90%19:30 EDT
Volume:330.59K
Turnover:680.42K
Market Cap:374.67M
PE:-2.23
High:2.09
Open:2.05
Low:2.02
Close:2.02
52wk High:3.04
52wk Low:0.4350
Shares:181.00M
Float Shares:101.00M
Volume Ratio:0.80
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-0.1107
ROE:-49.65%
ROA:-23.51%
PB:1.61
PE(LYR):-18.70

Loading ...

Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]